Security key
36151G105
INTELLIGENT BIO SOLUTIONS INC. - Common Stock, $0.01 par value (INBS)
CUSIP: 36151G105
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 533,641
- Total 13F value
- $416,000
- Share change
- +291,895
- SEC-reported price per share
- $0.78
- Number of holders
- 13
- Value change
- +$152,944
- Number of buys
- 11
- Number of sells
- 5
- Shares outstanding
- 1,637,347
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
13
Top holders
10
INBS full security history
Ownership snapshot
Full 13F holder table
INTELLIGENT BIO SOLUTIONS INC. SEC filings
INTELLIGENT BIO SOLUTIONS INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of INBS - INTELLIGENT BIO SOLUTIONS INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Life Science Biosensor Di...
Disclosed value leader
Life Science Biosensor Di...
Comparable rows
0/10
Latest evidence
17 Feb 2022
3/4/5
13F
Highest disclosed value: $2,001,337
10 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
Life Science Biosensor Diagnostics Pty Ltd has the largest disclosed position value at $2M.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Life Science Biosensor Diagnostics Pty Ltd's linked filing trail.
Disclosed position value
Top 5
Life Science Biosensor Diagnostic...
$2M
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$107K
WealthShield Partners, LLC
$71K
VANGUARD GROUP INC
$56K
JANE STREET GROUP, LLC
$36K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Life Science Biosensor Diagnostics Pty Ltd |
3/4/5
Former 10% owner
|
—
denominator unverified
|
$2,001,337
1,081,804 shares
|
— | 17 Feb 2022 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$107,000
75,000 shares
|
— | 31 Dec 2021 |
| WealthShield Partners, LLC |
13F
Company
|
—
denominator unverified
|
$71,000
49,147 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$56,000
38,925 shares
|
— | 31 Dec 2021 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$36,000
25,184 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$32,000
22,392 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
533,641
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2022 Across Filers
Q1 2022 holders
13
Q1 2022 holders
13
Holder diff
0
| Investor | Q1 2022 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q1 2022 value | Value change | Value Chg % |
|---|